SCHEMBL3853135

SCHEMBL3853135

COC(=O)Nc1nc2ccc(C(=O)c3ccccc3C(=O)Nc3cccc(F)c3)cc2[nH]1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAF1 P04049 5/20 0.72
▸ BRAF P15056 5/20 0.72
▸ KDR P35968 5/20 0.64
▸ MAPK1 P28482 2/20 0.64
▸ ADORA3 P0DMS8 1/20 0.64
▸ PTGS1 P23219 1/20 0.64
▸ RXFP1 Q9HBX9 1/20 0.64
▸ LMNA P02545 3/20 0.62
▸ CYP1A2 P05177 3/20 0.62
▸ ALDH1A1 P00352 2/20 0.62
▸ ABL1 P00519 2/20 0.62
▸ CYP2C9 P11712 2/20 0.62
▸ HTT P42858 2/20 0.62
▸ HIF1A Q16665 2/20 0.62
▸ ABCC4 O15439 1/20 0.62
▸ USP2 O75604 1/20 0.62
▸ TUBB4A P04350 3/20 0.55
▸ TUBB P07437 3/20 0.55
▸ TUBA3C P0DPH7 3/20 0.55
▸ TUBA1B P68363 3/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20525713 0.90 RAF1 (0.73) RAF1BRAFKDRMAPK1ADORA3
SCHEMBL3471881 0.90 RAF1 (0.59) RAF1BRAFKDRMAPK1ADORA3
SCHEMBL20525779 0.89 RAF1 (0.72) RAF1BRAFKDRMAPK1ADORA3
SCHEMBL20525848 0.87 RAF1 (0.70) RAF1BRAFKDRMAPK1ADORA3
SCHEMBL20525589 0.87 RAF1 (0.70) RAF1BRAFKDRMAPK1ADORA3
SCHEMBL20525682 0.86 RAF1 (0.69) RAF1BRAFKDRMAPK1ADORA3
SCHEMBL3857512 0.86 RAF1 (0.66) RAF1BRAFKDRMAPK1ADORA3
SCHEMBL1791971 0.81 RAF1 (0.64) RAF1BRAFKDRMAPK1ADORA3
SCHEMBL2357955 0.81 RAF1 (0.63) RAF1BRAFKDRMAPK1LMNA
SCHEMBL1468134 0.81 RAF1 (0.49) RAF1BRAFMAPK1LMNACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2101759-A1 METHODS OF USING MEK INHIBITORS Exelixis, Inc. (US) 2009-09-23 — — EP claimed
WO-2008076415-A1 METHODS OF USING MEK INHIBITORS EXELIXIS, INC. (US) 2008-06-26 — — WO claimed
Send feedback